Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Colorectal Cancer Screening and Detection, Gastric Cancer Management and Outcomes, Global Cancer Incidence and Screening, and Colorectal Cancer Surgical Treatments.
Exploring metabolomics for colorectal cancer risk prediction: evidence from the UK Biobank and ESTHER cohorts
Recent trends in self-reported utilization of colonoscopy and fecal occult blood test in Europe: analysis of the European Health Interview Surveys 2013–2015 and 2018–2020
Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study
Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018–2020
Utilization of colorectal cancer screening tests: a systematic review and time trend analysis of nationally representative data
Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis
Potential of pre-diagnostic metabolomics for colorectal cancer risk assessment or early detection
The underestimated preventive effects of flexible sigmoidoscopy screening: re-analysis and meta-analysis of randomized trials
An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations
Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the <scp>COVID‐19</scp> pandemic
Reduction in colorectal cancer incidence by screening endoscopy
Breast cancer screening programmes and self‐reported mammography use in <scp>European</scp> countries
When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
Colonoscopy-Ascertained Prevalence of Advanced Neoplasia According to Fecal Hemoglobin Concentration in a Large Cohort of Fecal Immunochemical Test–Negative Screening Participants
Overall and age‐specific risk advancement periods of colorectal cancer for men vs women: Implications for gender‐sensitive screening offers?
Which results would the NordICC trial have found if screening colonoscopy had prevented all incident colorectal cancers?
Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review
Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
Using risk advancement periods to derive starting ages of colorectal cancer screening according to sex and polygenic risk score: Results from the UK Biobank
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries
Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study
Polygenic Risk Score for Defining Personalized Surveillance Intervals After Adenoma Detection and Removal at Colonoscopy
Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany
Making colonoscopy‐based screening more efficient: A “gateopener” approach
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Incidence and Mortality of Proximal and Distal Colorectal Cancer in Germany
Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
Making colonoscopy-based screening more efficient: a ‘gateopener’ approach